Abstract:Autophagy and endoplasmic reticulum (ER) stress are conserved processes that generally promote survival, but can induce cell death when physiological thresholds are crossed. The pro-survival aspects of these processes are exploited by cancer cells for tumor development and progression. Therefore, anticancer drugs targeting autophagy or ER stress to induce cell death and/or block the pro-survival aspects are being investigated extensively. Consistently, several phytochemicals have been reported to exert their anticancer effects by modulating autophagy and/or ER stress. Various phytochemicals (e.g., celastrol, curcumin, emodin, resveratrol, among others) activate the unfolded protein response to induce ER stress-mediated apoptosis through different pathways. Similarly, various phytochemicals induce autophagy through different mechanisms (namely mechanistic target of Rapamycin [mTOR] inhibition). However, phytochemical-induced autophagy can function either as a cytoprotective mechanism or as programmed cell death type II. Interestingly, at times, the same phytochemical (e.g., 6-gingerol, emodin, shikonin, among others) can induce cytoprotective autophagy or programmed cell death type II depending on cellular contexts, such as cancer type. Although there is well-documented mechanistic interplay between autophagy and ER stress, only a one-way modulation was noted with some phytochemicals (carnosol, capsaicin, cryptotanshinone, guangsangon E, kaempferol, and δ-tocotrienol): ER stress-dependent autophagy. Plant extracts are sources of potent phytochemicals and while numerous phytochemicals have been investigated in preclinical and clinical studies, the search for novel phytochemicals with anticancer effects is ongoing from plant extracts used in traditional medicine (e.g., Origanum majorana). Nonetheless, the clinical translation of phytochemicals, a promising avenue for cancer therapeutics, is hindered by several limitations that need to be addressed in future studies.

Progress in phytochemicals′ induction of autophagic cell death in cancer cells and regulation of nuclear receptors

Interplay Between Apoptosis and Autophagy in Colorectal Cancer

Autophagy Regulators As Potential Cancer Therapeutic Agents: A Review

Autophagy-associated targeting pathways of natural products during cancer treatment.

Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents.

Natural autophagy regulators in cancer therapy: a review

Phytochemical-mediated modulation of autophagy and endoplasmic reticulum stress as a cancer therapeutic approach

Advances in indole-containing alkaloids as potential anticancer agents by regulating autophagy

Effect Of Autophagy On Chemotherapy-Induced Apoptosis And Growth Inhibition

Induction of Autophagic Death in Cancer Cells by Agonizing TR3 and Attenuating Akt2 Activity

Non-apoptotic cell death in malignant tumor cells and natural compounds

Natural small-molecule enhancers of autophagy induce autophagic cell death in apoptosis-defective cells

Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets

Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis

Autophagy modulation in cancer therapy

Advances in studies on flavonoids regulating autophagy in tumor cell lines

Targeting Autophagy with Natural Compounds in Cancer: A Renewed Perspective from Molecular Mechanisms to Targeted Therapy

Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment

Regulation of Autophagy by Non-Steroidal Anti-Inflammatory Drugs in Cancer.

Isoangustone A Induces Autophagic Cell Death in Colorectal Cancer Cells by Activating AMPK Signaling

Autophagy Regulators in Cancer